Insider · CIK 0001669080
David B. Weiner
Files at INO (INOVIO PHARMACEUTICALS, INC.). First filing -, latest -.
In brief
David B. Weiner files SEC Form 4 as director at INO (INOVIO PHARMACEUTICALS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; David B. Weiner has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 20, 2026 | INO INOVIO PHARMACEUTICALS, INC. | AGrant or award Common Stock Optionsderivative | +41,800 | $0.00 | $0 | 41,800 | May 21, 2026 |
| May 20, 2026 | INO INOVIO PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitderivative | +34,200 | $0.00 | $0 | 34,200 | May 21, 2026 |
| Feb 26, 2026 | INO INOVIO PHARMACEUTICALS, INC. | MOption exercise Common Stock | +972 | - | - | 87,592 | Feb 27, 2026 |
| Feb 26, 2026 | INO INOVIO PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitderivative | -972 | $0.00 | $0 | 0 | Feb 27, 2026 |
| May 21, 2025 | INO INOVIO PHARMACEUTICALS, INC. | MOption exercise Common Stock | +2,167 | - | - | 86,620 | May 21, 2025 |
| May 21, 2025 | INO INOVIO PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitderivative | -2,167 | $0.00 | $0 | 0 | May 21, 2025 |
| Feb 26, 2025 | INO INOVIO PHARMACEUTICALS, INC. | MOption exercise Common Stock | +972 | - | - | 83,481 | Feb 28, 2025 |
| Feb 26, 2025 | INO INOVIO PHARMACEUTICALS, INC. | MOption exercise Common Stock | +972 | - | - | 84,453 | Feb 28, 2025 |
| Feb 26, 2025 | INO INOVIO PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitderivative | -972 | $0.00 | $0 | 0 | Feb 28, 2025 |
| Feb 26, 2025 | INO INOVIO PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitderivative | -972 | $0.00 | $0 | 972 | Feb 28, 2025 |
Questions about David B. Weiner
Answered from the filings on this page, as of the latest one.
Is David B. Weiner buying or selling?
David B. Weiner has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did David B. Weiner's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David B. Weiner has 0.
Where does David B. Weiner file Form 4?
David B. Weiner has filed Form 4 at INO (INOVIO PHARMACEUTICALS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.